Multiple myeloma patients get continued access to promising drug

NCT ID NCT06057402

Recruiting now Disease control Sponsor: Pfizer Source: ClinicalTrials.gov ↗

First seen Nov 01, 2025 · Last updated Apr 25, 2026 · Updated 19 times

Summary

This study offers ongoing access to the drug elranatamab for people with multiple myeloma who were already benefiting from it in earlier Pfizer studies. About 80 participants will continue treatment and be monitored for side effects. The goal is to keep providing the drug while checking safety.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Arthur J.E. Child Comprehensive Cancer Centre
RECRUITING

Calgary, Alberta, T2N 5GN, Canada
Cross Cancer Institute
RECRUITING

Edmonton, Alberta, T6G 1Z2, Canada
Epworth Freemasons
NOT_YET_RECRUITING

Melbourne, Victoria, 3002, Australia
Epworth Hospital
NOT_YET_RECRUITING

Richmond, Victoria, 3121, Australia
Henry Ford Cancer - Detroit (Brigitte Harris Cancer Pavilion)
RECRUITING

Detroit, Michigan, 48202, United States
Japanese Red Cross Medical Center
RECRUITING

Shibuya-ku, Tokyo, 150-8935, Japan
Longs Peak Hospital
RECRUITING

Longmont, Colorado, 80504, United States
McGill University Health Centre
RECRUITING

Montreal, Quebec, H4A 3J1, Canada
National Taiwan University Hospital
RECRUITING

Taipei, 10002, Taiwan
Peking University Third Hospital
ACTIVE_NOT_RECRUITING

Beijing, Beijing Municipality, 100191, China
Shandong Provincial Hospital
RECRUITING

Jinan, Shandong, 250021, China
Slade Pharmacy
NOT_YET_RECRUITING

Richmond, Victoria, 3121, Australia
St. David's South Austin Medical Center
RECRUITING

Austin, Texas, 78704, United States
Sun Yat-sen University Cancer Center
ACTIVE_NOT_RECRUITING

Guangzhou, Guangdong, 510555, China
Sylvester Comprehensive Cancer Center
RECRUITING

Miami, Florida, 33136, United States
Sylvester Comprehensive Cancer Center - The Lennar Foundation Medical Center
RECRUITING

Coral Gables, Florida, 33146, United States
Taipei Veterans General Hospital
RECRUITING

Taipei, 11217, Taiwan
The first Affiliated Hospital, Zhejiang University School of Medicine
RECRUITING

Hangzhou, Zhejiang, 310003, China
UCHealth - Medical Center of the Rockies
RECRUITING

Loveland, Colorado, 80538, United States
UCHealth Greeley Hospital
RECRUITING

Greeley, Colorado, 80634, United States
UCHealth Harmony
RECRUITING

Fort Collins, Colorado, 80528, United States
UCHealth Longs Peak Medical Center
RECRUITING

Longmont, Colorado, 80504, United States
UCHealth Poudre Valley Hospital
RECRUITING

Fort Collins, Colorado, 80524, United States
University Hospital,Kyoto Prefectural University of Medicine
RECRUITING

Kyoto, 602-8566, Japan
University of Miami Hospital and Clinics
RECRUITING

Miami, Florida, 33136, United States
University of Miami Hospital and Clinics - Griffin Cancer Research Building
RECRUITING

Miami, Florida, 33136, United States
University of Miami Hospital and Clinics Deerfield Beach
RECRUITING

Deerfield Beach, Florida, 33442, United States
University of Michigan
RECRUITING

Ann Arbor, Michigan, 48109, United States

Conditions

Explore the condition pages connected to this study.

MULTIPLE MYELOMA